The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patientsMatthew Kennedy, Mark S. Forman, Marissa F. Dockendorf et al.|Science Translational Medicine|2016Cited by 416